| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | 4 | — | — | — | — | — | 1 | — |
| total | individual payouts | |
|---|---|---|
| 2024 | ‡‡‡ |
|
| 2023 | ‡‡‡ |
|
| 2022 | 0.85 |
—
—
—
—
|
| 2021 | 0.83 |
—
—
—
—
|
| 2020 | 0.81 |
—
—
—
—
|
| 2019 | 0.79 |
—
—
—
—
|
| 2018 | 0.77 |
—
—
—
—
|
| 2017 | 0.75 |
—
—
—
—
|
| 2016 | 0.73 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 147.46 | 135.77 | 203.89 | 200.87 |
| Receivables | 383.51 | 382.34 | 334.79 | 324.13 |
| Inventory | 18.48 | 16.75 | 16.80 | 15.84 |
| Other | 40.73 | 38.55 | 59.98 | 48.19 |
| 571.70 | 556.65 | 576.42 | 568.53 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 83.22 | 81.15 | 77.38 | 86.10 |
| ST’ Debt | 25.00 | — | — | — |
| Other | 194.25 | 167.40 | 146.00 | 165.99 |
| 216.93 | 192.55 | 170.38 | 188.12 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 462.77 | 470.81 | — | — |
—
|
| ’25 | 447.66 | 458.49 | 464.34 | 466.68 |
1,837.17
|
| ’24 | 423.43 | 426.29 | 428.15 | 437.81 |
1,715.68
|
| ’23 | 417.23 | 418.93 | 411.39 | 423.84 |
1,671.39
|
| ’22 | 426.81 | 424.86 | 414.49 | 424.02 |
1,690.18
|
| ’21 | 407.75 | 398.17 | 415.59 | 420.45 |
1,641.96
|
| ’20 | 449.15 | 452.03 | 435.95 | 423.18 |
1,760.30
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 43.73 | 21.87 | — | — |
—
|
| ’25 | 27.50 | 28.79 | 71.29 | 17.39 |
144.97
|
| ’24 | (26.03) | 16.32 | 4.31 | 36.20 |
30.80
|
| ’23 | (16.29) | 7.40 | 2.94 | 49.45 |
43.50
|
| ’22 | (30.18) | 9.02 | (9.90) | 22.89 |
(8.17)
|
| ’21 | 3.50 | 25.34 | (23.11) | 31.38 |
37.11
|
| ’20 | 12.69 | 79.70 | 49.17 | 75.66 |
217.21
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 42.39 | 20.33 | — | — |
—
|
| ’25 | 25.78 | 27.48 | 69.97 | 16.03 |
139.26
|
| ’24 | (28.21) | 15.13 | 2.96 | 34.80 |
24.68
|
| ’23 | (17.24) | 6.34 | 1.10 | 48.01 |
38.21
|
| ’22 | (31.44) | 7.89 | (11.47) | 22.03 |
(12.98)
|
| ’21 | 2.71 | 24.13 | (25.10) | 29.90 |
31.63
|
| ’20 | 12.03 | 78.83 | 48.10 | 74.20 |
213.15
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.37 | 0.32 | — | — |
—
|
| ’25 | 0.23 | (0.44) | 0.59 | 0.44 |
0.81
|
| ’24 | 0.21 | (0.02) | 0.19 | 0.16 |
0.53
|
| ’23 | 0.17 | 0.12 | (0.07) | 0.31 |
0.52
|
| ’22 | 0.15 | 0.09 | 0.00 | 0.22 |
0.47
|
| ’21 | 0.33 | 0.13 | 0.13 | 0.03 |
0.61
|
| ’20 | 0.27 | 0.31 | 0.37 | 0.37 |
1.32
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 11.55 | 8.75 | 8.98 | 9.13 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 20.54 | 15.97 | 13.00 | 20.26 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 35,700 | 33,400 | 35,300 | 36,000 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.05 | 0.05 | 0.05 | 0.05 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,690.18 | 1,671.39 | 1,715.68 | 1,837.17 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.44% | 12.85% | 13.29% | 13.03% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 44.55 | 53.06 | 52.94 | 67.87 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.64% | 3.17% | 3.09% | 3.69% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 34.24 | 38.39 | 39.47 | 59.06 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.54 | 16.49 | 16.09 | 17.07 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 22.74 | 22.50 | 23.26 | 25.38 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 0.47 | 0.52 | 0.54 | 0.82 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.11) | 0.59 | 0.42 | 2.00 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.06) | (0.07) | (0.08) | (0.08) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.17) | 0.51 | 0.33 | 1.92 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.63 | 6.15 | 6.78 | 7.05 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 74.34 | 74.29 | 73.75 | 72.38 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 27.17 | 20.08 | 21.52 | 23.32 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.55 | 0.47 | 0.50 | 0.75 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.22 | 1.73 | 1.71 | 2.71 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.50 | 0.41 | 0.44 | 0.66 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (64.76) | 17.78 | 30.71 | 8.74 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (8.17) | 43.50 | 30.80 | 144.97 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (4.82) | (5.28) | (6.12) | (5.71) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (12.98) | 38.21 | 24.68 | 139.26 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 319.62 | 354.77 | 364.11 | 406.04 | — | — | — |
Working Cap'
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 33.10 | 25.00 | — | — | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (88.38) | (122.46) | (135.77) | (203.89) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 418.28 | 456.62 | 499.93 | 510.21 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.57% | 5.08% | 4.95% | 7.40% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.03% | 8.97% | 7.73% | 9.90% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.86% | 8.77% | 8.25% | 11.69% | — | — | — |
ROE
|
Healthcare Services Group (HCSG), a resilient provider of outsourced housekeeping, laundry, food, and facility services to nursing homes and hospitals, has weathered a decade of headwinds including the COVID-19 crisis, labor shortages, and cost inflation. Revenue peaked at $2 billion in 2018 before contracting to $1.72 billion in 2024, yet operational efficiency has shone through: revenue per employee surged 33% to $48,603 amid a 36% workforce reduction, stabilizing the stock in the low teens after a plunge from mid-50s highs. This echoes historical service-sector recoveries where productivity gains precede broader rebounds, signaling HCSG’s potential inflection point.
Profitability faces margin pressures from wage inflation (labor ~70% of costs), with EBT margins slipping to 3.1% and ROE to 8.3%, but forecasts paint a brighter path: revenue growth accelerating to 7% in 2025 and EPS doubling to $1.09 by 2027, supported by demographic tailwinds like an aging population and outsourcing trends. A pristine balance sheet—net cash position of -$136 million, cumulative FCF ~$500 million—funds buybacks and dividends (4-5% yield), while valuations scream value at 0.5x sales and 1.7x book, far below pre-pandemic norms.
Analyst targets imply 11% average upside amid sparse insider activity (one sell, no buys), with risks from labor costs and policy shifts tempered by management refresh and cash fortress. HCSG’s turnaround narrative, blending efficiency offsets and projected growth, merits close watch for Q1 2026 earnings—potentially catalyzing a re-rating in this undervalued healthcare niche.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.